|
Bonnie A. Charpentier
Bonnie A. Charpentier is an American chemist. In 2019, she served as the president of the American Chemical Society (ACS) and is a past chair of its board of directors. She is also the Senior Vice President of Regulatory Affairs and Compliance at Cytokinetics. Education Bonnie Charpentier completed a bachelor's degree in anthropology in 1974 and a Ph.D. in plant physiology in 1981, both at the University of Houston. Her early interest in herbal folk medicines first drew her into anthropology and plant science, then into analytical chemistry and her career overseeing regulatory affairs, quality, and drug safety at pharmaceutical companies. Career Bonnie Charpentier joined the biopharmaceutical firm Cytokinetics as their Senior Vice President of Regulatory Affairs and Compliance in 2014. Before that, she was Vice President of Regulatory Affairs and Quality at Metabolex (now CymaBay Therapeutics). She also previously held various roles at Genitope Corp, Roche Global Deve ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Cytokinetics
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. History Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998. Initially, Cytokinetics focused on the possible pharmacological targets and areas of application of drugs based on cytoskeletal proteins. Eventually, the company narrowed its focus to the mechanics of muscle biology. Cytokinetics develops muscle activators and muscle inhibitors to improve muscle function in patients with cardiovascular and neuromuscular diseases. In 2004 the company completed its initial public offering (IPO). In January 2007, Cytokinetics named Robert I. Blum as president and CEO. Prior to this, Blum has been involved ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |